CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist - Wikidata - awgldk - TriplyDB

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist

http://www.wikidata.org/entity/Q28254222

about

Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D₃ receptor antagonists.Targeting the dopamine D3 receptor: an overview of drug design strategies.Pramipexole derivatives as potent and selective dopamine D(3) receptor agonists with improved human microsomal stability.Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D2/D3 Receptor Agonist Selectivity.Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds.

P2860

Q28828620-3D6E5C17-1FB3-4EB6-BECD-8C5FCAB06CC6 Q34435684-D42115B5-97AD-4653-93E0-CF6A54D4DFAF Q34524556-5DED3263-8270-4C37-BECA-DC7377CACB54 Q34775660-3DC41C16-B0FA-46E5-9FA4-8E260041694C Q37025051-569DD76A-296A-40D2-8FCD-74272A67C279 Q38656262-B1A7CED3-F66A-401B-A894-2FAAAA0E5BFF

P2860

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist

http://www.wikidata.org/entity/Q28254222

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist

@ast

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist

@en

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist

@nl

type

label

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist

@ast

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist

@en

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist

@nl

prefLabel

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist

@ast

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist

@en

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist

@nl

P1433

Q28254222-82DE2C51-CB4E-4593-B8FF-4277F3F1942F

P1476

Q28254222-314A8B45-8F06-480A-A0CF-FE48ABC9FF06

P2093

Q28254222-346A235B-D5A6-4A9E-B59A-B1C4788A7363

Q28254222-4AC9E291-91A3-4922-B059-111DA7A36C90

Q28254222-9C36CEF1-8F90-4424-A4EE-7426AADF3400

Q28254222-FEAF2D8E-C30A-4036-8045-FE912AC9AB19

P2860

Q28254222-024E8E16-3BD2-4D52-B768-11FFF69C3A96

Q28254222-1555FE89-65C7-446F-AEC6-EBDFD8F49217

Q28254222-1D30F6D3-8B9A-483C-B260-7037DCBAA4E3

Q28254222-1EE4F511-B708-4E9D-99A1-12F0D3F6185C

Q28254222-20AFEF53-E61D-46DD-8615-1A0759BB4DE8

Q28254222-3FBC853B-AE1B-4114-BCEB-22D19FCA9700

Q28254222-43DAF4E5-5461-477D-BA5A-BB8EEEB19993

Q28254222-8275AE9F-1F9C-40B0-BF1B-57C23ECE6EB4

Q28254222-ACB0B157-1131-4F7B-BD1E-AE9683E2570A

Q28254222-B7B26C25-A71C-48E3-B27A-5CDA0D243F46

P304

Q28254222-CF78544D-EBB2-4EE1-B4FE-01E85B8C5EF8

P31

Q28254222-2ACCC8DA-A0B2-470E-86FD-5CCC2F34D46E

P356

Q28254222-3B763B00-D642-483E-BB14-7546F7168F79

P407

Q28254222-5F64E79D-44B5-4CC3-A630-AC1E9F56FB9F

P433

Q28254222-04CB39F7-7450-49EF-BDF0-970E631903CB

P478

Q28254222-49A80432-AE0C-478F-AA0A-A8DD8305C4CA

P50

Q28254222-24C69B2C-63E0-47D1-A6EE-D1420F807EF9

Q28254222-AD23E5F6-26FB-4350-B798-4EB012A33890

P577

Q28254222-D76CC5A4-1110-4F11-8D80-04B4146E5E9D

P5875

Q28254222-001FC7A0-EBB6-4988-BC0B-1ECEA211920A

P698

Q28254222-EBAFE67C-E8F7-4D4F-9547-A3FFBDCFCCFF

P921

Q28254222-103B91BD-C9FE-4AF9-AF63-ACCC375245F2

Q28254222-55D87B3F-B09B-4B1E-9BE3-49125CDBBE76

Q28254222-bf856dfd-2c38-4ba0-bbc2-8c9c4b51787f

P932

Q28254222-1D79C312-0683-49AF-9CEC-39359FF0368B

P356

P1433

ACS Medicinal Chemistry Letters

P1476

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist

@en

P2093

Beth Levant

http://www.w3.org/2001/XMLSchema#string

Gregory T Collins

http://www.w3.org/2001/XMLSchema#string

James Woods

http://www.w3.org/2001/XMLSchema#string

Jianyong Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile

N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A

Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists

Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.

Evidence for regulation of body temperature in rats by dopamine D2 receptor and possible influence of D1 but not D3 and D4 receptors.

3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor.

Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs.

Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies.

P304

620-625

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ML200100T

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey R. Deschamps

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51838543

http://www.w3.org/2001/XMLSchema#string

P698

22125662

http://www.w3.org/2001/XMLSchema#string

P921

Aagianik kimischri

P932

3224040

http://www.w3.org/2001/XMLSchema#string